Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bunsimgi-eum is a polyherbal formulation used in Traditional Korean Medicine (TKM) to treat neuropsychiatric and psychosomatic symptoms associated with emotional stress. It is traditionally indicated for 'stagnation of the seven emotions' and is a primary treatment for Hwa-byung, a Korean culture-bound syndrome characterized by suppressed anger and physical symptoms such as chest discomfort, palpitations, and heat sensations. The formulation typically contains approximately 15 to 20 herbal ingredients, including *Cyperus rotundus*, *Perilla frutescens*, and *Citrus reticulata*. Clinical research has evaluated its efficacy in randomized, placebo-controlled trials, though results regarding its superiority over placebo for specific somatic symptoms like chest discomfort have been mixed.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bunsimgi-eum.